Northwestern University Human Resources

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1851-01-28

Employees: 5K

Market Cap: -

Website: https://www.venturecat.northwestern.edu

Clinical Trials

Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer

Early Phase 1

Conditions: Endometrial Endometrioid Adenocarcinoma

Interventions: Drug: Abemaciclib
Drug: Letrozole
Procedure: Therapeutic Conventional Surgery

First Posted Date: 2019-08-08

Last Posted Date: 2021-05-03

Lead Sponsor: Northwestern University

Target Recruit Count: 27

Registration Number: NCT04049227

Locations: 🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States

Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Phase 1

Active, not recruiting

Conditions: Glioblastoma

Interventions: Drug: IDO1 Inhibitor BMS-986205 25mg
Drug: Nivolumab
Radiation: Radiation Therapy
Drug: IDO1 Inhibitor BMS-986205 100 mg
Drug: IDO1 Inhibitor BMS-986205 50 mg
Drug: Temozolomide

First Posted Date: 2019-08-07

Last Posted Date: 2024-08-15

Lead Sponsor: Northwestern University

Target Recruit Count: 18

Registration Number: NCT04047706

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

IntelliCare in College Students

Not Applicable

Completed

Conditions: Depression
Anxiety

Interventions: Behavioral: Mobile self-help intervention

First Posted Date: 2019-07-29

Last Posted Date: 2020-10-08

Lead Sponsor: Northwestern University

Target Recruit Count: 20

Registration Number: NCT04035577

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 2

Conditions: Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents
Stage IVB Prostate Cancer AJCC v8
Prostate Carcinoma Metastatic in the Soft Tissue
PSA Progression
Testosterone Less Than 50 ng/dL
Castration Levels of Testosterone
Prostate Carcinoma Metastatic in the Bone
Metastatic Prostate Adenocarcinoma
Castration-Resistant Prostate Carcinoma
Progressive Disease

Interventions: Biological: Recombinant EphB4-HSA Fusion Protein

First Posted Date: 2019-07-26

Last Posted Date: 2022-04-27

Lead Sponsor: Northwestern University

Target Recruit Count: 14

Registration Number: NCT04033432

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

fMRI Study of tES in Major Depression

Early Phase 1

Completed

Conditions: Depression

Interventions: Device: Transcranial Electrical Stimulation (tES)

First Posted Date: 2019-07-24

Last Posted Date: 2023-02-09

Lead Sponsor: Northwestern University

Target Recruit Count: 11

Registration Number: NCT04031547

Locations: 🇺🇸
Center for Translational Imaging at Northwestern University, Chicago, Illinois, United States

Platelet-rich Plasma for Eyebrows

Phase 2

Recruiting

Conditions: Eyebrow Hypotrichosis

Interventions: Device: Platelet Rich Plasma Prep System
Drug: Saline

First Posted Date: 2019-07-15

Last Posted Date: 2024-03-15

Lead Sponsor: Northwestern University

Target Recruit Count: 30

Registration Number: NCT04018859

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Cost and Quality in Consumer Sunscreen Preferences

Completed

Conditions: Healthy

Interventions: Other: Survey

First Posted Date: 2019-07-11

Last Posted Date: 2021-07-12

Lead Sponsor: Northwestern University

Target Recruit Count: 487

Registration Number: NCT04016441

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Evaluation of a Symptom and Needs Assessment for Patients With Cancer

Completed

Conditions: Cancer

Interventions: Other: Symptom Monitoring Intervention

First Posted Date: 2019-07-10

Last Posted Date: 2023-01-26

Lead Sponsor: Northwestern University

Target Recruit Count: 1166

Registration Number: NCT04014751

Locations: 🇺🇸
Northwestern Medicine, Chicago, Illinois, United States

Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast

Phase 2

Recruiting

Conditions: Ductal Breast Carcinoma In Situ
Invasive Breast Carcinoma
Cancer Survivor

Interventions: Drug: Afimoxifene
Procedure: Core Biopsy
Other: Questionnaire Administration

First Posted Date: 2019-07-05

Last Posted Date: 2023-07-13

Lead Sponsor: Northwestern University

Target Recruit Count: 156

Registration Number: NCT04009044

Locations: 🇺🇸
University of Illinois Cancer Center, Chicago, Illinois, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States

Coordinating Pragmatic Primary Care Population Management for Obesity

Not Applicable

Completed

Conditions: Cardiovascular Risk Factor
Obesity

Interventions: Behavioral: Outreach Support for Weight Loss Goal Setting and Self-Weighing
Behavioral: Outreach Decision Support to Encourage Linkages to Intensive Community Lifestyle Interventions
Behavioral: Adaptive Tailoring of Information Delivery and Intensity of Primary Care Outreach Support

First Posted Date: 2019-06-25

Last Posted Date: 2022-02-22

Lead Sponsor: Northwestern University

Target Recruit Count: 80

Registration Number: NCT03998046

Locations: 🇺🇸
Northwestern Medicine, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy